- Research
- Patents
Patents
The following is a list of VIDO's awarded Canadian and U.S. patents:
Date | Location | Patent Number | Patent Name | Inventors |
---|---|---|---|---|
July 14/20 | CDN |
2,909,193 |
Prion disease-specific epitopes and methods of use thereof |
Marciniuk, K.; Taschuk, R.; Napper, S.; Potter, A.; Cashman, N. |
Sept 3/19 | CDN |
2,842,872 |
Recombinant swine influenza virus and uses thereof |
Zhou, Y.; Masic, A. |
Jan 8/19 | CDN | 2,757,828 | Methods and compositions for treating and preventing Shiga Toxin-producing Escherichia Coli infection | Potter, A.; Asper, D.; Rogan, D. |
Oct 16/18 | US | 10,098,944 | Recombinant swine influenza virus and uses thereof | Zhou, Y.; Masic, A. |
Nov 7/17 | US | 9,809,620 | Prion disease-specific epitopes and methods of use thereof | Marciniuk, K.; Taschuk R.; Napper, S.; Potter, A.; Cashman, N. |
Nov 7/17 | CDN | 2,410,665 | Modified bovine adenovirus having altered tropism | Tikoo, S. |
Jun 27/17 | CDN | 2,737,352 | Combination adjuvant formulation | van Drunen Littel-van den Hurk, S., Gerdts, V., Potter, A., Babiuk, L., Hancock, R., Halperin, S., Mutwiri, G., Elliott, M., Kindrachuk, J., Kovacs-Nolan, J., Lee, S., Kweon, M.-N. |
Aug 9/16 | US | 9,408,908 | Combination adjuvant formulation | van den Hurk, S.; Gerdts, V.; Potter, A.; Babiuk, L.; Hancock, R.; Halperin, S.; Kovacs-Nolan, J.; Mutwiri, G.; Lee, S., Kweon, M.; Kindrachuk, J.; Elliott, M. |
June 28/16 | US | 9,376,476 | Prion epitopes and methods of use thereof | Napper, S.; Hedlin, P.; Griebel, P.; Babiuk, L.; Cashman, N.; Chukrabartty, A.; Potter, A. |
May 10/16 | CDN | 2,527,721 | Chimeric adenovirus capsid proteins | Tikoo, S.; Zakhartchouk, A., Babiuk, L., Kaushik, R., Griebel, P. |
Dec 22/15 | CND | 2,594,375 | Bovine Adenovirus Type 3 Genome | Babiuk, L.; Tikoo, S.; Reddy, P. |
Aug 11/15 | US | 9,102,754 | Immunomodulatory compositions and methods for treating disease with modified host defense peptides | Napper, S.; Kindrachuk, J.; Attah-Poku, S. |
June 23/15 | US | 9,061,001 | Combination adjuvant formulation | van den Hurk, S.; Gerdts, V.; Potter, A.; Babiuk, L.; Hancock, R.; Halperin, S.; Kovacs-Nolan, J.; Mutwiri, G.; Lee, S., Kweon, M.; Kindrachuk, J.; Elliott, M. |
June 16/15 | US | 9,056,918 | Prion epitopes and methods of use thereof | Napper, S.; Babiuk, L.; Griebel, P.; Hedlin, P. |
July 29/14 | CDN | 2,718,812 |
Porcine adenovirus type 3 genome |
Babiuk, L.; Tikoo, S.; Reddy, P. |
May 27/14 | US | 8,734,811 |
Methods and compositions for treating and preventing Shiga Toxin-producing Escherichia coli infection |
Potter, A.; Asper, D.; Rogan, D. |
Jan 29/13 | CDN | 2,325,574 | Porcine Adenovirus Type 3 genome | Babiuk, L.; Tikoo, S.; Reddy, P. |
Nov 27/12 | CDN | 2,461,579 | Porcine adenovirus E1 region | Tikoo, S. |
Aug 7/12 | CDN | 2,411,927 | Immunization of dairy cattle with GapC protein against Streptococcus infection | Bolton, A.; Perez-Casal, J.; Fontaine, M.; Potter, A. |
July 31/12 | CDN | 2,411,919 | Immunization of dairy cattle with chimeric GapC protein against Streptococcus infection | Potter, A.; Perez-Casal, J.; M. Fontaine |
Feb 7/12 | CDN | 2,222,701 | Camp factor of Streptococcus uberis | Jiang, M.; MacLachlan, P.; Potter, A. |
Feb 2/12 | CDN | 2,349,760 | Bovine cells expressing adenovirus essential functions for propagation of recombinant adenoviral vectors | Tikoo, S.; Babiuk, L.; Reddy, P. |
Aug 16/11 | CDN | 2,411,925 | Immunization of Dairy Cattle with Mig protein | Potter, Andrew A.; Bolton, Alexandra; Song, Xin-Ming |
July 6/10 | US | 7,749,516 | Immunization of dairy cattle with GapC protein against Streptococcus infection | Bolton, A.; Potter, A.; Perez-Casal, J.; Fontaine, M. |
April 20/10 | US | 7,700,117 | Camp factor of Streptococcus uberis | Potter, A.; Perez-Casal, J.; Fontaine, M.; Song, X. |
Mar 30/10 | US | 7,687,615 | PAV Regions for encapsidation and E1 transcriptional control | Tikoo, S |
Aug 4/09 | US | 7,569,217 | Porcine adenovirus E1 and E4 regions | Tikoo, S. |
July 14/09 | US | 7,560,278 | Methods to culture circovirus | Liu, Q; Tikoo, S.; Willson, P.; Babiuk, L. |
Mar 24/09 | US | 7,507,411 | Attenuated Influenza NS1 variants | Zhou, Y.; Shin, Y-K.; Babiuk, L.; Liu, Q |
Aug 19/08 | CDN | 2,442,135 | Methods to culture circovirus | Liu, Q; Tikoo, S.; Willson, P.; Babiuk, L. |
Feb 26/08 | US | 7,335,353 | Porcine cells comprising an adenovirus E3 gene region | Reddy, P.; Tikoo, S.; Babiuk, L. |
Sept 25/07 | CDN | 2,294,649 | Bovine adenovirus type 3 genome | Babiuk, L.; Tikoo, S.; Reddy, P. |
Sept 25/07 | US | 7,273,930 | Immunization of dairy cattle with GapC protein against Streptococcus infection | Bolton, A.; Potter, A.; Perez-Casal, J.; Fontaine, M. |
Sept 4/07 | US | 7,264,818 | BAV packaging regions and E1 transcriptional control regions | Tikoo, S.; Xing, L. |
Aug 21/07 | US | 7,258,992 | Immunization of dairy cattle with GapC protein against Streptococcus infection | Potter, A.; Perez-Casal, J.; Fontaine, M. |
Mar 27/07 | CDN | 2,133,441 | Haemophilus somnus immunogenic proteins | Potter, A.; Pontarollo, R.; Pfeiffer, C.; Theisen, M.; Harland, R.; Rioux, C. |
Feb 6/07 | US | 7,172,899 | Methods to culture circovirus | Liu, Q.; Tikoo, S.; Willson, P.; Babiuk, L. |
Sept 5/06 | CDN | 2,099,707 | Haemophilus Somnus outer membrane protein extract enriched with iron-regulated proteins | Potter, A.; Harland, R. |
Apr 11/06 | US | 7,025,967 | Recombinant protein production in bovine adenovirus expression vector system | Mittal, S.; Graham, F.; Prevec, L.; Babiuk, L. |
Sept 20/05 | US | 6,946,448 | In utero nucleic acid immunization | Gerdts, V.; Babiuk, L.; van den Hurk, S., Griebel, P. |
June 21/05 | US | 6,908,619 | Camp factor of Streptococcus uberis | Jiang, M.; Potter, A.; MacLachlan, R. |
May 3/05 | US | 6,887,686 | Cloning and expression of Haemophilus somnus transferring-binding proteins | Potter, A.; Rioux, C; Schryvers, A. |
Mar 15/05 | US | 6,866,855 | Immunization of dairy cattle with GapC protein against Streptococcus infection | Bolton, A.; Perez-Casal, J.; Fontaine, M.; Potter, A. |
Feb 1/05 | US | 6,849,446 | Modified bovine adenovirus having altered tropism | Tikoo, S.; Babiuk, L.; Zhang, L.; Wu, Q. |
Dec 21/04 | US | 6,833,134 | Immunization of dairy cattle with GapC protein against Streptococcus infection | Bolton, A; Perez-Casal, J., Fontaine, M; Potter, A. |
Sept. 28/04 | US | 6,797,272 | Enhanced immunogenicity using leukotoxin chimeras | Potter, A.; Redmond, Mark J.; Hughes, Huw P.A. |
Sept. 21/04 | US | 6,794,163 | Methods to culture circovirus | Liu, Qiang; Tikoo, Suresh Kumar; Willson, Philip; Babiuk, Lorne A. |
May 25/04 | US | 6,740,322 | Immunization of dairy cattle with Mig protein | Potter, Andrew A.; Bolton, Alexandra; Song, Xin-Ming |
Dec 9/03 | US | 6,660,270 B2 |
Immunization of dairy cattle with chimeric GapC protein against Streptococcus infection | Potter, Andrew A.; Perez-Casal, Jose; Fontaine, Michael |
Aug 26/03 | US | 6,610,506 B1 |
Transferrin binding proteins of Pasteurella haemolytica and vaccines containing same | Reggie, Y.C.Lo; Schryvers, A.B.; Potter, Andrew A. |
Feb. 18/03 | US | 6,521,746 B1 |
Polynucleotides Encoding LKT 111 | Potter, Andrew A.; Manns, John G. |
Dec. 10/02 | US | 6,492,343 | Porcine adenovirus Type 3 genome | Reddy; Police Seshidhar,; Tikoo; Suresh Kumar; Babiuk; Lorne A. |
Oct. 1/02 | US | 6,458,586 | Bovine cells expressing adenovirus essential functions for propagation of recombinant adenoviral vectors | Tikoo; Suresh Kumar; Babiuk; Lorne A.; Reddy; Police Seshidhar |
May 21/02 | US | 6,391,316 | Vaccine compositions comprising Haemophilus somnus transferrin-binding proteins and methods of use | Potter; Andrew A.; Rioux; Clement; Schryvers; Anthony B. |
Apr. 30/02 | US | 6,379,944 | Mammalian cell lines expressing bovine adenovirus functions | Mittal; Suresh K.; Graham; Frank L.; Prevec; Ludvik; Babiuk; Lorne A.; Tikoo; Suresh Kumar |
Nov. 20/01 | CDN | 2,089,753 | Interleukin-2-leukotoxin gene fusions and uses thereof | Potter, Andrew; Campos, Manuel; Hughes, Huw P. A. |
Nov. 20/01 | US | 6,319,716 | Bovine adenovirus type 3 genome and vector systems derived therefrom | Tikoo; Suresh Kumar; Babiuk; Lorne A.; Reddy; Police Seshidhar; Zakhartchouk; Alexandre; Baxi; Mohit |
Sept. 19/00 | CDN | 2,065,365 | Bovine coronavirus polypeptides and vaccines |
Parker, Michael D.; Cox, Graham, J.; Babiuk, Lorne A. |
Aug. 8/00 | US | 6,100,066 | Nucleic acid molecules encoding Haemophilus somnus proteins | Potter; Andrew A.; Theisen; Michael; Harland; Richard J.; Rioux; Clement R. |
Aug. 1/00 | US | 6,096,320 | Vaccines with chimeric protein comprising gamma-interferon and leukotoxin derived from pasteurella haemolytica | Potter; Andrew; Campos; Manuel; Hughes; Huw P. A. |
July 11/00 | US | 6,086,902 | Recombinant bovine herpesvirus type 1 vaccines | Zamb; Timothy; Liang; Xiaoping; Babiuk; Lorne A. |
July 11/00 | US | 6,086,890 | Bovine adenovirus expression vector system | Mittal; Suresh K.; Graham; Frank L.; Prevec; Ludvik; Babiuk; Lorne A. |
July 11/00 | US | 6,086,880 | Rotavirus peptide compositions and methods of use | Sabara; Marta Iris Johanna; Frenchick; Patrick John; Potter; Andrew Allan; Ijaz; Mohammad Khalid; Gilchrist; James Elton; Redmond; Mark J. |
Feb. 8/00 | US | 6,022,960 | GnRH-leukotoxin chimeras | Potter; Andrew A.; Manns; John G. |
Dec. 14/99 | US | 6,001,591 | Recombinant bovine adenoviruses | Mittal; Suresh K.; Graham; Frank L.; Prevec; Ludvik; Babiuk; Lorne A. |
Nov. 16/99 | US | 5,985,289 | Haemophilus somnus outer membrane protein extract enriched with iron-regulated proteins | Potter; Andrew A.; Harland; Richard J. |
Oct. 19/99 | US | 5,969,126 | GNRH-leukotoxin chimeras | Potter; Andrew A.; Manns; John G. |
Sept. 14/99 | US | 5,951,988 | Adjuvant formulation with enhanced immunogenic activity, and related compositions and methods | Littel-van den Hurk; Sylvia van Drunen; Zamb; Timothy; Redmond; Mark J. |
Apr. 6/99 | US | 5,891,677 | Actinobacillus pleuropneumoniae outer membrane lipoprotein A and uses thereof | Gerlach; Gerald F.; Willson; Philip J.; Rossi-Campos; Amalia; Potter; Andrew A. |
Mar. 9/99 | US | 5,879,895 | Recombinant bovine herpesvirus type 1 polypeptides and immunoassays | Babiuk; Lorne; van den Hurk; Sylvia; Zamb; Tim; Fitzpatrick; David |
Mar. 2/99 | US | 5,876,725 | Actinobacillus pleuropneumoniae transferrin binding protein vaccines and uses thereof | Potter; Andrew A.; Gerlach; Gerald F.; Willson; Philip J.; Rossi-Campos; Amalia |
Feb. 16/99 | US | 5,871,750 | Leukotoxin vaccine compositions and uses thereof | Potter; Andrew A. |
Jan. 26/99 | US | 5,863,543 | Camp factor of streptococcus uberis | Jiang; Min; Potter; Andrew A.; MacLachlan; Philip Ronald |
Jan. 12/99 | US | 5,858,989 | Vaccines comprising nucleotide sequences encoding bovine herpesvirus type 1 g1, g111 and gIV | Babiuk; Lorne; van den Hurk; Sylvia; Zamb; Tim; Fitzpatrick; David |
Dec. 15/98 | US | 5,849,531 | Compositions and treatments for pneumonia in animals | Potter; Andrew A. |
Nov. 17/98 | US | 5,837,268 | GnRH-leukotoxin chimeras | Potter; Andrew A.; Manns; John G. |
Oct. 13/98 | US | 5,820,868 | Recombinant protein production in bovine adenovirus expression vector system | Mittal; Suresh K.; Graham; Frank L.; Prevec; Ludvik; Babiuk; Lorne A. |
Sept. 1/98 | US | 5,801,018 | Vaccines for Actinobacillus pleuropneumoniae | Potter; Andrew A.; Gerlach; Gerald F.; Willson; Philip J.; Rossi-Campos; Amalia |
May 5/98 | US | 5,747,309 | Bacterial vaccines using vaccine strains of pathogenic bacteria | Allan; Brenda J.; Potter; Andrew A. |
Mar. 3/98 | US | 5,723,129 | GnRH-leukotoxin chimeras | Potter; Andrew A.; Manns; John G. |
Jan. 13/98 | US | 5,708,155 | Enhanced immunogenicity using leukotoxin chimeras | Potter; Andrew A.; Redmond; Mark J.; Hughes; Huw P. A. |
Sept. 30/97 | US | 5,672,350 | Recombinant bovine coronavirus E2 and E3 polypeptides and vaccines | Parker; Michael D.; Cox; Graham J.; Babiuk; Lorne A |
Aug. 8/97 | CDN | 2,262,524 | GnRH Leukotixin Chimeras | Potter, Andrew A.; Manns, John |
Jan 14/97 | US | 5,594,107 | Chimeric protein comprising an RTX-family cytotoxin and interferon-2 or interferon | Potter; Andrew A.; Campos; Manuel; Hughes; Huw P. A. |
Dec. 17/96 | US | 5,585,264 | Nucleotide sequences encoding recombinant bovine herpesvirus type-1 GI, GIII and GIV polypeptides | Babiuk; Lorne; van den Hurk; Sylvia; Zamb; Tim; Fitzpatrick; David |
July 9/96 | US | 5,534,256 | Haemophilus somnus outer membrane protein extract enriched with iron-regulated proteins | Potter; Andrew A.; Harland; Richard J. |
May 28/96 | US | 5,521,072 | Actinobacillus pleuropneumoniae transferrin binding proteins and uses thereof | Potter; Andrew A.; Gerlach; Gerald F.; Willson; Philip J.; Rossi-Campos; Amalia |
Apr. 2/96 | US | 5,503,833 | VP6 encapsulated drug delivery | Redmond; Mark J.; Campos; Manuel |
Feb. 26/96 | CDN | 1,338,069 | Bovine herpesvirus Type 1 polypeptides and vaccines | Babiuk, Lorne A.; van den Hurk, Sylvia; Zamb, Tim; Fitzpatrick, David |
Dec. 19/95 | US | 5,476,657 | Pasteurella haemolytica leukotoxin compositions and uses thereof | Potter; Andrew A. |
Aug. 15/95 | US | 5,441,736 | Actinobacillus pleuropneumoniae outer membrane lipoprotein A and uses thereof | Gerlach; Gerald F.; Willson; Philip J.; Rossi-Campos; Amalia; Potter; Andrew A. |
July 11/95 | US | 5,431,899 | Rotavirus VP6 as a diagnostic and targeting agent | Redmond; Mark J.; Campos; Manuel; Matte; Gilbert G.; Haines; Deborah M. |
June 6/95 | US | 5,422,110 | Enhanced immunogenicity using leukotoxin chimeras | Potter; Andrew A.; Redmond; Mark J.; Hughes; Huw P. A. |
May 23/95 | US | 5,417,971 | Vaccines for Actinobacillus pleuropneumoniae | Potter; Andrew A.; Gerlach; Gerald F.; Willson; Philip J.; Rossi-Campos; Amalia |
Dec. 20/94 | US | 5,374,426 | Rotavirus nucleocapsid protein VP6 in vaccine compositions | Sabara; Marta I.; Frenchick; Patrick J.; Mullin-Ready; Kerry F. |
Nov. 29/94 | US | 5,369,026 | DNA encoding bovine coronavirus polypeptides E2 and E3 | Parker; Michael D.; Cox; Graham J.; Babiuk; Lorne A. |
Mar. 29/94 | US | 5,298,244 | Assembled viral particles and their use in a vaccine to rotaviral disease | Redmond; Mark J.; Ijaz; Mohammed K.; Parker; Michael D. |
Feb. 15/94 | CDN | 1,327,096 | Peptides corresponding to antigenic and immunogenic determinants of major neutralizing proteins of rotaviruses | Sabara, Marta I.; Frenchick, Patrick J.; Potter, Andrew A.; Gilchrist, James E.; Ijaz, Mohammad K. |
Dec. 28/93 | US | 5,273,889 | Gamma-iterferon-leukotoxin gene fusions and uses thereof | Potter; Andrew; Campos; Manuel; Hughes; Huw P. A. |
Oct. 26/93 | US | 5,256,560 | Primitive cell colony stimulating factors and lymphohematopoietic progenitor cells | Lawman; Michael J. P.; Ohmann; Helle B.; Attah-Poku; Samuel K.;Heise-Qualtiere; Janette |
Aug. 24/93 | US | 5,238,823 | Interleukin-2-leukotoxin gene fusions and uses thereof | Potter; Andrew; Campos; Manuel; Hughes; Huw P. A. |
Aug. 10/93 | US | 5,234,684 | Method for the prevention and treatment of bovine mastitis | Sordillo; Lorraine M.; Babiuk; Lorne A. |
June 15/93 | CDN | 1,319,101 | Rotavirus nucleocapsid protein with or without binding peptides as immunologic carriers for macromolecules | Sabara, Marta Iris; Frenchick, Patrick John; Mullin-Ready, Kerry Frances |
May 18/93 | US | 5,212,156 | SRIF-related peptides and uses thereof | Laarveld; Bernard; Kirkwood; Roy N.; Thacker; Philip A.; Sordillo; Lorraine M.; Redmond; Mark |
Feb. 9/93 | CDN | 2,014,033 | Compositions and treatments for pneumonia in animals | Acres, Stephen D.; Babiuk, Lorne A.; Potter, Andrew A.; Lawman, Michael J.P. |
Sept. 29/92 | US | 5,151,267 | Bovine herpesvirus type 1 polypeptides and vaccines | Babiuk; Lorne; van den Hurk; Sylvia; Zamb; Tim; Fitzpatrick; David |
June 23/92 | US | 5,124,145 | Method for the prevention and treatment of bovine mastitis | Sordillo; Lorraine M.; Babiuk; Lorne A. |
Dec. 10/91 | US | 5,071,651 | Rotavirus nucleocapsid protein VP6 as a carrier in vaccine compositions | Sabara; Marta I.; Frenchick; Patrick J.; Mullin-Ready; Kerry F. |
Sept. 17/91 | US | 5,049,378 | Prevention and treatment of porcine haemophilus pneumonia (PHP) | Campos; Manuel |
Nov. 3/91 | US | 4,298,597 | Vaccine for diarrhea caused by E. coli | Acres; Stephen D. ; Kapitany; Robert A. |
May 24/83 | CDN | 1,146,882 | Anucleated live E. coli vaccine | Khachatourians, George G. |